Asahi Kasei - Request for proposals

31 January 2023

Proposals are due by Tuesday 28 February 2023.

Areas of interest are briefed below, but more detail can be found at:

https://www.asahikasei-pharma.co.jp/a-compass/en/#concept

Autoimmune Disease:  

1.     Primary Sjögren’s syndrome (pSS)
2.     Systemic lupus erythematosus (SLE) and Lupus Nephritis
3.     Immunological Kidney Diseases
4.     Systemic Sclerosis
5.     Other drug development technologies for autoimmune disease

Kidney Disease:

1.     Genetic Renal Diseases
2.     Immunological Kidney Diseases
3.     Drug development technologies for renal disease

Neurodegenerative Disease:

1.     Polyglutamine Disease
2.     Synucleinopathy, Tauopathy, and TDP-43 Proteinopathy
3.     Drug development technologies for neurodegenerative disease

Bone Diseases:

1.     Suppression of heterotopic ossification

Chronic Pain:

1.     Neuropathic pain
2.     OA (osteoarthritis) pain
3.     Low back pain

Please contact Heather Ramsay (h.ramsay@qmul.ac.uk) if you have any questions.